BrainStorm Cell Therapeutics Inc. (OTC.QB:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it will hold a conference call on Tuesday, November 19, 2013 at 8:45 a.m. Eastern Standard Time (EST), 15:45 Israel Standard Time (IST). Mr. Chaim Lebovits, President and Principal Executive Officer, will update shareholders on the latest positive company developments. The call will be conducted in English, with Q&A in both English and Hebrew.
Help employers find you! Check out all the jobs and post your resume.
